← back to search

Yayi Hou

Nanjing University of Chinese Medicine · CN
Area of research
Immunology
Research interest
Research focused on Cancer research and CD8, with related work in Colorectal cancer, Oxaliplatin, Hyperthermia. Notable publications include 'Ferrimagnetic Vortex Nanoring-Mediated Mild Magnetic Hyperthermia Imparts Potent Immunological Effect for Treating Cancer Metastasis', 'C. tropicali s promotes chemotherapy resistance in colon cancer through increasing lactate production to regulate the mismatch repair system', and 'Magnetic hyperthermia induces effective and genuine immunogenic tumor cell death with respect to exogenous heating'.
h-index
citations
154
works
7
NIH funding
primary concept
email

Recent publications

Durable antitumor response via an oncolytic virus encoding decoy-resistant IL-18
Journal for ImmunoTherapy of Cancer 2024cited by 6position: middledoi
TLR5 expression marks brain boarder associated macrophages and protects neonatal mice from bacterial meningitis
hLife 2024cited by 3position: middledoi
Magnetic hyperthermia induces effective and genuine immunogenic tumor cell death with respect to exogenous heating
Journal of Materials Chemistry B 2022cited by 39position: middledoi
Notch1 signalling controls the differentiation and function of myeloid‐derived suppressor cells in systemic lupus erythematosus
Immunology 2022cited by 8position: middledoi
<i>C. tropicali</i>s promotes chemotherapy resistance in colon cancer through increasing lactate production to regulate the mismatch repair system
International Journal of Biological Sciences 2021cited by 47position: middledoi
Bornlisy Attenuates Colitis-Associated Colorectal Cancer via Inhibiting GPR43-Mediated Glycolysis
Frontiers in Nutrition 2021cited by 15position: middledoi
Ferrimagnetic Vortex Nanoring-Mediated Mild Magnetic Hyperthermia Imparts Potent Immunological Effect for Treating Cancer Metastasis
ACS Nano 2019cited by 227position: middledoi
Tumor-Infiltrating CD1a+ DCs and CD8+/FoxP3+ Ratios Served as Predictors for Clinical Outcomes in Tongue Squamous Cell Carcinoma Patients
Pathology & Oncology Research 2019cited by 36position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Wenyue Yan · Nanjing University of Chinese Medicine2 papers (2021–2021)Yuxian Song · China Pharmaceutical University2 papers (2019–2024)Xiaowei Ma · Hebei Medical University2 papers (2019–2022)Haiming Fan · Ministry of Education of the People's Republic of China2 papers (2019–2022)Junxing Qu · China Pharmaceutical University2 papers (2021–2021)Xiaoli Liu · National University of Singapore2 papers (2019–2022) · 1 papers (2024–2024)Chun Lu · Third Affiliated Hospital of Sun Yat-sen University1 papers (2024–2024)Qingang Hu · Nanjing Agricultural University1 papers (2019–2019)Fei Fei · Fudan University1 papers (2022–2022)Yue Jing · Hubei University of Medicine1 papers (2019–2019)Weikang Sun · China Pharmaceutical University1 papers (2024–2024)Sunan Shen · China Pharmaceutical University1 papers (2021–2021)Zhen Xu · Shandong University1 papers (2021–2021)Tingbin Zhang · Ministry of Education of the People's Republic of China1 papers (2019–2019)Xia Lu · Nanjing Medical University1 papers (2021–2021)Xiaofeng Huang · Nanchang University1 papers (2019–2019)Yuanhui Zhao · Hebei Medical University1 papers (2024–2024)Yan Cheng · Nantong University1 papers (2024–2024)Yang Du · Pennsylvania State University1 papers (2019–2019)